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Abstract: - This research is titled  “Awareness on Polycystic Ovarian Syndrome: A Comparative Study on the Health-Related 
Quality of Life between Diagnosed and Undiagnosed Women Aged 18-49” which aimed to identify the difference in the health-
related quality of life (HRQoL) among the diagnosed and undiagnosed women ages 18-49 years old within the National Capital 
Region, who have the signs and symptoms of Polycystic Ovarian Syndrome (PCOS), and are adequately aware of the disorder. The 
study was comparative and quantitative in nature. It was conducted using the PCOS Awareness and Health Management 
Questionnaire through the use of Google Forms, with a minimum sample size of 385 respondents that had undergone participant 
screening. Data analysis involved the measures of central tendency, independent t-test, and paired t-test for data treatment. Majority 
of the respondents were aged 18-25, single, and lived in Quezon City. The most prevalent among the signs and symptoms of PCOS 
was irregular menstrual cycle or having no period at all. The psychological effects of PCOS were reported as follows: (1) sometimes, 
among the Undiagnosed PCOS Group; (2) often, among the Diagnosed PCOS Group Pre-treatment; (3) sometimes, among the Post-
treatment. Meanwhile, the physiological effects are as follows: (1) often, among the Undiagnosed PCOS Group; (2) often, among 
the Diagnosed PCOS Group Pre-treatment; and (3) rarely, among the Post-treatment. There was a significant difference in the 
psychological and physiological effects between both the Undiagnosed PCOS Group and Diagnosed PCOS Group Pre-treatment 
(p<0.05), and the diagnosed group before and after treatment (p<0.05). The most common reasons for rejecting diagnosis for the 
Undiagnosed and Diagnosed PCOS Groups were due to the fear of getting diagnosed and because the treatment is expensive, 
respectively. The most common reason for seeking diagnosis for the Undiagnosed PCOS Group is to have a healthier lifestyle, while 
for the Diagnosed PCOS Group it is to reduce further complications. The improvement in the HRQoL of women after receiving 
diagnosis suggests that clinical diagnosis is beneficial because a better comprehension of PCOS is obtained after diagnosis. This 
influences behavior to aim towards health maintenance and an improved health-related quality of life. 
Key Words: — Polycystic Ovarian Syndrome, PCOS, Health-related quality of life, HRQoL, Awareness, Women.
I. INTRODUCTION 
Polycystic Ovarian Syndrome (PCOS), or polycystic 
ovary syndrome, is defined as the combination of anovulation 
(infertility, oligomenorrhea, and dysfunctional uterine  
bleeding) and hyperandrogenism (acne and hirsutism) 
(Witchel, Oberfield, & Peña, 2019). It is most often associated 
with the imbalance of the sex hormones and the presence of 
obesity, diabetes mellitus, insulin resistance, metabolic 
syndrome, dyslipidemia, hypertension, cardiovascular disease 
(CVD), hyperplasia, and endometrial carcinoma (Barbosa et al., 
2016). This syndrome involves 6-10% of women in menacme, 
the time of a woman’s life between the first menstruation and 
menopause, and is considered as the main gynecological 
disease of the endocrine gland in reproductive age (Fabio & 
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Melissa, 2020). Due to anovulation, it is also considered as the 
leading cause of female infertility. 
Three main characteristics are attributed to PCOS: the 
presence of cysts in the ovaries, high levels of male hormones, 
and the irregularity of having periods. In individuals who have 
PCOS, there is not enough threshold to trigger ovulation 
because the eggs in the sacs or follicles of the ovaries do not 
mature. The lack of ovulation alters levels of progesterone, 
estrogen, luteinizing hormone (LH), and follicle stimulating 
hormone (FSH); thus individuals with PCOS produce higher-
than-normal amounts of male hormones which cause the 
irregularity of menstruation and difficulty to bear a child (Garad 
& Teede, 2020). 
Health-related quality of life (HRQoL) is a multi-dimensional 
concept, which focuses on the impact of health status on quality 
of life. Through the use of HRQoL, clinicians and public health 
officials are able to measure the effects of chronic illness, 
treatments, and short- and long-term disabilities (Office of 
Disease Prevention and Health Promotion, 2020). 
According to the US National Library of Medicine National 
Institutes of Health (2018), approximately 75% of women 
remained undiagnosed for PCOS after visiting a physician due 
to the variability of patient presentation and lack of provided 
information. The symptoms of PCOS cannot be easily 
determined unless after consultation due to complaints related 
to menstrual irregularities, heavy bleeding, hair growth, acne, 
weight gain, male pattern baldness, headache, and formation of 
dark patches in the neck, groin, and under the breast (Watson, 
2021). Care provision between health disciplines persists to be 
fragmented resulting in delays in diagnosis, dissatisfaction with 
information provision, and variation in clinical assessment and 
management (Barbosa et al., 2016). 
The signs and symptoms of PCOS tend to be disregarded 
because of their commonality and the lack of information on 
the long-term consequences. Lack of awareness and health 
management may lead to infertility, endometrial cancer, 
obesity, dyslipidemia, hypertension, diabetes, dysfunctional 
bleeding, and the theoretical increased risk of CVD (Wolf et al., 
2018). Between 70-80% of infertility in women was due to 
having PCOS (Melo et al., 2015). According to the Herdin 
(2017), 61 out of 487 women with endometrial cancer at the 
premenopausal age group had PCOS. Of the 487 women, PCOS 
also displayed a direct correlation with obesity (62.30%). Up to 
70% of women with PCOS had abnormal levels of cholesterol 
and lipids in the blood (Sivanandy, 2019). A study by Chen et 
al. (2014) also showed that PCOS patients had higher insulin, 
lipid, and glucose compared to the latter. Additionally, the 
prevalence of hypertension in women with PCOS was higher 
compared to normotensive individuals with an 19.2% 
prevalence rate. Up to 40% of women with PCOS could 
develop prediabetes and 10% actually lead to having diabetes 
(Basile & Rodriguez, 2020). According to the US National 
Library of Medicine National Institutes of Health (2012), PCOS 
patients are at risk of CVD due to the unusual hormonal 
patterns. 
In a study by Copp et al. (2019), prior to diagnosis, some 
women experienced struggles to conceive and bothersome 
symptoms; however, this feeling later on turned to relief of 
being diagnosed and resulted in an increased understanding on 
the importance of a healthy lifestyle. Positive coping strategies 
were developed over time, indicating the importance of timely 
and accurate diagnosis of PCOS. 
This study sought to raise awareness on the long-term outcome 
of PCOS and to encourage women to undergo clinical diagnosis 
to avoid further complications. Awareness of PCOS can aid the 
linkage to care, increased screening for comorbidities, and 
improvement for patient care. Early diagnosis is also essential 
in addressing symptoms, identifying infertility, improving 
quality of life, and avoiding long term sequelae caused by 
metabolic, cardiovascular, and psychosocial complications 
associated with the condition. 
1.1 Objectives of the Study 
The general objective of this study was to compare the 
health-related quality of life (HRQoL) between women 
diagnosed with Polycystic Ovarian Syndrome (PCOS) and 
undiagnosed women who have signs and symptoms of PCOS, 
aged 18-49 in the National Capital Region. 
Specific Objectives: 
• Identify and compare the demographic profile of the 
women who are exhibiting the signs and symptoms of 
Polycystic Ovarian Syndrome (PCOS) for the past 
three months. Identify the prevalence of the 
psychological and physiological effects of the signs 
and symptoms of PCOS among: 
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a. Undiagnosed PCOS Group 
b. Diagnosed PCOS Group Pre-treatment 
c. Diagnosed PCOS Group Post-treatment 
• Identify the significant difference in the psychological 
and physiological effects of the signs and symptoms 
of PCOS between: 
d. Undiagnosed PCOS Group and Diagnosed 
PCOS Group Pre-treatment 
e. Diagnosed PCOS Group Pre-treatment and 
Diagnosed PCOS Group Post-treatment 
• Identify the most common factors that affect the 
decision to seek and reject diagnosis of PCOS among 
the Undiagnosed PCOS Group and Diagnosed PCOS 
Group. 
1.2 Hypothesis of the Study 
Ho: There is no significant difference in the health-related 
quality of life among the diagnosed and undiagnosed women 
experiencing the signs and symptoms of Polycystic Ovarian 
Syndrome, aged 18-49 in the National Capital Region. 
Ha: There is a significant difference in the health-related 
quality of life among the diagnosed and undiagnosed women 
experiencing the signs and symptoms of Polycystic Ovarian 
Syndrome, aged 18-49 in the National Capital Region. 
1.3 Research Impediments 
The study was limited to the comparison of women 
who were clinically diagnosed with Polycystic Ovarian 
Syndrome (PCOS) and women who were not diagnosed but are 
experiencing the indicative signs and symptoms of the disorder 
concerning their perception of their overall health management. 
The study was conducted to a minimum of 385 qualified 
respondents experiencing the indicative signs and symptoms of 
PCOS. The minimum number of respondents needed for the 
study was determined through the Raosoft sample size 
calculator, where a targeted 5% margin of error and 95% 
confidence interval yielded the value of the said sample size. 
Women selected for participation in this study were only those 
within the reproductive age (18-49 years old) and who were 
residents of the National Capital Region, Philippines. The 
Undiagnosed PCOS Group was selected using the additional 
criteria: had an adequate level of awareness of PCOS and its 
signs and symptoms, had at least one sign or symptom of 
hyperandrogenism, and had one sign or symptom of 
oligoovulation. All criteria were assessed through participant 
screening before the questionnaire proper. The study was 
conducted during the second semester of the Academic Year 
2020-2021 through Google Forms. Usage of strictly non-face-
to-face measures of data gathering and participant recruitment 
were done for the entirety of the research process. 
1.4 Significance of the Study 
This study aimed to compare the health-related quality of life 
between women diagnosed with Polycystic Ovarian Syndrome 
(PCOS) and undiagnosed women who have the signs and 
symptoms of PCOS. It also aimed to recognize and promote 
awareness among women of reproductive age on the medical 
significance, clinical symptoms of PCOS, and its long-term 
complications. With varying clinical manifestations, PCOS 
remains to be a diagnosis of exclusion; it is difficult to identify 
unless a proper course of laboratory tests have been performed 
to confirm the diagnosis. The disorder tends to be overlooked 
due to its commonality of symptoms and lack of information on 
long-term complications. This study aimed to increase patient 
engagement by promoting an environment for addressing 
misconceptions, raising awareness, and improving quality of 
life. Collecting significant data such as the extent of knowledge 
on the disorder and reasons for being undiagnosed will help 
encourage platforms of information and proper patient 
counselling among health and educational institutions. 
1.5 Conceptual Framework 
Fig.1. The conceptual framework of the study about the health-
related quality of life between women diagnosed with PCOS and 
undiagnosed women who have the signs and symptoms of PCOS. 
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The conceptual framework displayed the input, process or 
methodology, and the expected output of the study. The inputs 
comprise the responses of the subjects in the provided 
questionnaire. These responses include the demographic profile 
of the subjects, prevalence of the common signs and symptoms 
of PCOS, prevalence of respondents clinically diagnosed with 
PCOS, the psychological and physiological effects of the signs 
and symptoms of PCOS on the Undiagnosed PCOS Group, the 
psychological and physiological effects before and after 
treatment of the Diagnosed PCOS Group, and the factors that 
affect the health-seeking and rejecting behavior towards 
diagnosis between the two subject groups. 
The process included data collection and data analysis. The 
assessment tool that was used for data collection was the PCOS 
Awareness and Health Management Questionnaire. A 
participant screening was utilized to obtain eligible respondents 
for the study. Data analysis utilized frequency count, measure 
of central tendency (average weighted mean), and t-test 
treatment on the data obtained from the respondents. 
The expected output of the study on PCOS discussed the 
difference in the HRQoL between diagnosed and undiagnosed 
women with PCOS. The difference in HRQoL between the two 
subjects was based on the comparison of the frequencies of the 
effects of the signs and symptoms of PCOS and the factors that 
affect their decision towards diagnosis. Specifically, to assess 
HRQoL, the following were determined: the significant 
difference in the effects of the signs and symptoms of PCOS 
among the Undiagnosed PCOS Group, the Diagnosed PCOS 
Group before treatment, and the Diagnosed PCOS Group after 
treatment; and the factors and reasons affecting the reasons for 
accepting or rejecting diagnosis. Through this, HRQoL among 
the Undiagnosed and Diagnosed PCOS Groups was assessed 
and differentiated to determine if there are possible advantages 
or disadvantages of health-seeking behavior and diagnosis. 
II. METHODOLOGY 
2.1 Research Design 
The study was comparative and quantitative in nature, 
where it aimed to identify a difference of the health-related 
quality of life (HRQoL) between diagnosed and undiagnosed 
women with Polycystic Ovarian Syndrome (PCOS) through 
quantitative means. This was determined through the 
administration, scoring, and interpretation of a PCOS 
awareness and health management questionnaire through an 
online form. Collection of data employed the use of snowball 
and convenience non-probability sampling in order to collect 
samples that were most useful to the purposes of the research, 
that passed the sample criteria, and that were most accessible to 
the researcher. Factors that were identified were the presence of 
factors that may affect HRQoL and the prevailing signs and 
symptoms. Quantitative methods such as frequency count and 
percentage frequency, measure of central tendency (AWM), 
independent t-test, and paired t-test treatments were used to 
compare the groups. 
2.2 Subjects and Study Site 
The study required the respondents to be females 
within reproductive age (18-49 years old) and are residing 
within the National Capital Region (NCR), Philippines. The 
respondents must be aware of the medical condition of PCOS 
and must be experiencing at least one symptom of 
oligoovulation, and exhibiting at least one of the observable 
signs and symptoms of PCOS. 
There were two significant subject groups in this study: women 
clinically diagnosed with PCOS (Diagnosed PCOS Group) and 
women who are experiencing the signs and symptoms of PCOS 
but are not clinically diagnosed (Undiagnosed PCOS Group). 
The former group was subdivided into the effects of PCOS 
before treatment (Pre-treatment) and after treatment (Post-
treatment).  
The Diagnosed PCOS Group Pre-treatment is the group of 
women who have been diagnosed with PCOS but have not yet 
undergone treatment, while the Diagnosed PCOS Group Post-
treatment is the group of women who have already undergone 
treatment. A minimum of 385 qualified samples from both 
groups were evaluated for this study. Using a 5% margin of 
error and 95% confidence interval, a total of 385 respondents 
was the determined minimum sample size using the Raosoft 
sample size calculator.  
The Diagnosed PCOS Group was required to present a medical 
certificate or medical laboratory report as evidence of diagnosis 
after answering the questionnaire. 
The collection of respondents was done through online means 
specifically, Google Forms. The use of social platforms such as 
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Facebook, Twitter, and Google Mail were used to gather and 
select samples, and to disseminate the questionnaire. 
2.3 Polycystic Ovarian Syndrome (PCOS) Awareness 
and Health Management Questionnaire 
The Polycystic Ovarian Syndrome (PCOS) Awareness 
and Health Management Questionnaire was adapted from the 
Journal of Clinical Endocrinology and Metabolism (Cronin et 
al., 1998) article, “Development of Health-Related Quality-of-
Life Questionnaire (PCOSQ) for women with Polycystic Ovary 
Syndrome (PCOS)”. This assessment tool was distributed using 
Google Forms and through the means of social platforms such 
as Facebook, Twitter, and Google Mail. Since the questionnaire 
was adapted, it has already been used by several researchers and 
evaluated in previous studies; hence, there was no need to test 
for its validity. 
The questionnaire was composed of two parts; the first part 
contained the participant screening while the second part was 
about the PCOS awareness and health management 
questionnaire. The first part served as the screening of willing 
respondents who fall under the following sample criteria: 
within the ages of 18-49, living in the National Capital Region, 
have an awareness of PCOS, currently experiencing at least one 
symptom of oligoovulation, and exhibiting at least one of the 
observable signs and symptoms of PCOS. The second part or 
the questionnaire proper was composed of questions regarding 
the participants demographic profile (age, civil status, and 
location) and contained eight sections: signs and symptoms, 
psychological and physiological signs and symptoms, 
prevalence of diagnosed and undiagnosed respondents, post-
psychological and post-physiological signs and symptoms, 
factors or reasons for rejecting diagnosis, factors or reasons for 
seeking diagnosis, confirmation, and referral. Questions 
regarding the psychological and physiological effects of the 
signs and symptoms of PCOS, and the factors for rejecting and 
seeking diagnosis were used as an assessment to check the 
impact of PCOS on the respondents’ health-related quality of 
life. 
A brief introduction on the purpose of the study as well as an 
assurance that participating in the study will include full 
confidentiality of their identity was stated before the 
questionnaire proper. The questionnaire contained questions 
with a list of choices and 4-point Likert scale questions. It was 
also available in English and Filipino languages. The estimated 
time needed to accomplish the questionnaire was 10-15 minutes 
and participants were instructed to answer all applicable 
questions. At the end of the questionnaire, an overview on the 
definition of PCOS and its associated long-term health effects 
were stated. In addition, referral links and contact numbers of 
the National Center for Mental Health, Medgate Philippines, 
and Globe Telehealth, Inc. were indicated should the 
participants have inquiries or concerns regarding mental health 
and consultation. 
2.4 Data Gathering Procedure 
 
Fig.2. Data gathering and analysis procedure performed throughout 
the course of the study. 
Questionnaires were employed as the method of data 
collection. The target respondents were females diagnosed with 
Polycystic Ovarian Syndrome (PCOS) and females 
undiagnosed with the disorder but exhibit its signs and 
symptoms; respondents must also be within 18-49 years of age 
and reside in the National Capital Region (NCR), Philippines at 
the time of answering the questionnaire. The study was 
conducted for 10 months, one month of which was used for data 
gathering. The estimated time for answering the questionnaire 
was 10-15 minutes. The study excluded minors, women outside 
the reproductive age (aged 50 years and above), and women 
living outside of NCR, Philippines. The level of awareness of 
PCOS was measured on a scale of 0-5; those who have an 
answer of number 2 or above in the participant screening of the 
questionnaire are included in the study as it guarantees that 
respondents are knowledgeable of at least the symptoms of 
PCOS. Additionally, those who presented as diagnosed but 
failed to submit proof of their diagnosis without a valid reason 
within two weeks from the submission of the questionnaire 
proper were excluded from the study. 
To initiate the recruitment of respondents, convenience 
sampling was employed in which publication materials and the 
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Google Forms questionnaire were posted in Facebook, Twitter, 
and Google Mail, and were propagated via shares, and retweets. 
A consent form which outlines the objectives of the study in 
detail and ensures confidentiality was included in order to 
minimize pressures that would urge respondents to either forfeit 
from the study or not give their honest responses. A participant 
screening was employed to identify the eligible respondents. 
Other potential respondents were determined through snowball 
or chain-referral sampling to increase the likelihood of finding 
women that fit the target population. The survey was distributed 
to more than 385 respondents. Among the participants who 
underwent participant screening, a minimum of 385 qualified 
samples from the Diagnosed PCOS Group and Undiagnosed 
PCOS Group were evaluated. Once a respondent has given her 
informed consent and has been qualified, she will then answer 
the PCOS Awareness and Health Management Questionnaire. 
Women categorized under  the  Diagnosed  PCOS  Group  were  
asked  to present proof of their diagnosis. They are given two 
weeks from the submission of the questionnaire proper to 
submit a file of their medical certificate or proof of being 
diagnosed with PCOS. No study-related treatments or medical 
procedures were performed on the study. The data was analyzed 
using the appropriate statistical measure. 
2.5 Ethical Considerations 
An informed consent was provided to all participants prior to 
their involvement in the study. The participant’s involvement is 
completely voluntary. In the event that the respondents have a 
concern regarding the content of the questionnaire, contact 
details of the National Center for Mental Health, Medgate 
provided at the end of the questionnaire. The anonymity of the 
participants was strictly observed throughout the study and the 
researchers ensured that their identities and the information that 
were collected was solely for the purpose of the study. The 
study did not have a source of financial support and the authors 
declared no conflict of interest. 
2.6 Data Analysis 
The data analysis of the collected results from the respondents 
was conducted with the use of IBM SPSS Statistics (Version 
23) in order to determine the indications of the collected data to 
the study. Treatment for the data collected from the participants 
involved the use of descriptive statistics such as frequency 
count and percentage frequency for the demographic profile, 
and the factors for rejecting and seeking diagnosis. A measure 
of the central tendency, particularly average weighted mean 
(AWM), was utilized for the prevalence of the psychological 
and physiological effects of the signs and symptoms of 
Polycystic Ovarian Syndrome (PCOS). The determination of 
the mean was performed on the basis of a 4-point Likert scale. 
A Descriptive Equivalent (DE) with ranges was utilized to 
describe each mean. 
The Independent t-test was applied to compare the 
Undiagnosed PCOS Group and Diagnosed PCOS Group before 
treatment. Independent t-test was applicable for the data 
because the two groups being compared were separate and 
independent of each other. A level of significance of 95% was 
applied to this test. On the other hand, the Paired Samples t-test 
was used to compare the Diagnosed PCOS Group before and 
after their treatment. The test evaluated the responses to 
measure two different intervals from a related group. A level of 
significance of 95% was applied to this test. 
III. RESULTS 
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The 403 respondents of the study were initially assessed 
through their demographic profile. Table.1. shows that the 
majority of the respondents’ age, civil status, and location 
within the National Capital Region (NCR) are 18-25 (90.3%), 
Single (96.5%), and Quezon City (18.4%), respectively. They 
were also divided into the Diagnosed PCOS Group and the 
Undiagnosed PCOS Group. As seen in Table 2, 245 (60.8%) of 
the 403 respondents belong to the Undiagnosed PCOS Group 
while 158 (39.2%) belong to the Diagnosed PCOS Group. 




Fig.3. Frequency Count of the Number of the Signs or Symptoms 
Experienced by the Respondents. 
The most prevalent signs or symptoms of PCOS in all of the 
respondents were identified in Table 3 through frequency 
count, where Irregular menstrual cycle or having no period 
PCOS. Additionally, in Figure 3, it was noted how many signs 
or symptoms are experienced by a respondent and they were 
grouped based on whether they are diagnosed or not. Majority 
of the diagnosed respondents reported having 7 signs or 
symptoms of PCOS (22.15%), while the undiagnosed group 
commonly had 5 (24.49%). 
The psychological and physiological effects of the signs and 
symptoms of PCOS were identified. In the succeeding tables, 
respondents from the Diagnosed PCOS group were asked for 
two separate data, their current experiences and their 
experiences before receiving treatment for PCOS, thus dividing 
the group into Pre-treatment, and Post-treatment. 
  All in all, this resulted in three groups for data analysis: 
Undiagnosed PCOS Group, Diagnosed PCOS Group Pre-
treatment, and Diagnosed PCOS Group Post-treatment. Data 
treatment determined the average weighted mean (AWM) of 
the psychological and physiological effects with a descriptive 
equivalent and a corresponding set of ranges.  
The following ranges were indicated for the mean scores in 
increasing order: 1.00-1.75 for Rarely; 1.76-2.50 for 
Sometimes; 2.51- 3.25 for Often; and 3.26-4.00 for Always. 
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Table   4.1 displays that, in general, psychological effects Often  
affected  the  respondents,  as  shown  by  an AWM of 2.64. 
Feel frightened of getting cancer (3.17) was the most common 
psychological effect. When it comes to the specific groups, the 
Undiagnosed PCOS Group was Sometimes affected (2.48) by 
psychological effects with Feel frightened of getting cancer 
being the most common (3.16); the Diagnosed PCOS Group 
Pre-Treatment was Often affected (2.87) with Feel concerned 
in gaining weight as the most common (3.35); lastly, the 
Diagnosed PCOS Group Post-Treatment was Sometimes 
affected by these effects (2.18) with Feel frightened of getting 
cancer as the most prevalent effect. 
Table 4.2 shows that physiological effects Often affected the 
respondents as a whole (2.67). Irregular menstrual periods 
(2.67) was the most common physiological effect. For the 
specific groups, all three had Irregular menstrual periods as the 
most prevalent effect. The Undiagnosed PCOS Group, 
Diagnosed PCOS Group Pre-Treatment, and Diagnosed PCOS 
Group Post-Treatment had an AWM of 3.30, 3.53, and 1.98, 
respectively. In terms of burden from all the physiological 
effects combined, the Undiagnosed PCOS group was Often 
affected (2.58), the Diagnosed PCOS  Group Pre-Treatment 
was also Often affected (2.81), while the Diagnosed PCOS 
Group Post-Treatment was Rarely affected (1.69). 
An Independent Sample t-test was used in order to determine 
the significant difference in the psychological and 
physiological effects between the Undiagnosed PCOS Group 
and Diagnosed PCOS Group Pre-treatment as seen in Table 
For the psychological effects, the results showed that the t-
computed (6.186) is greater than the critical value (1.96). On 
the other hand, the results showed that the t-computed (3.96) is 
greater than the critical value (1.96) for the physiological 
effects. Both the psychological and physiological effects 
presented a p-value or significant value of 0.000 which is less 
than 0.05. This means that there is a significant difference in 
the psychological and physiological effects of the signs and 
symptoms between the Undiagnosed PCOS Group and 
Diagnosed PCOS Group Pre-treatment. 
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In Table 6, a Paired Sample t-test was used in order to determine 
the significant difference in the psychological and 
physiological effects of the signs and symptoms of PCOS 
between the Diagnosed PCOS Group Pre-treatment and 
Diagnosed PCOS Group Post-treatment. For the psychological 
effects of PCOS on both groups, the results showed that the t-
computed (18.399) is greater than the critical value (1.96). The 
same goes for the physiological effects of PCOS on the 
Diagnosed PCOS Group Pre-treatment and Post-treatment, 
where the results displayed that the t–computed (22.193) is 
greater than critical value (1.96). Both the psychological and 
physiological effects of the signs and symptoms of PCOS on 
the two groups had a p-value or significant value of 0.000, 
which is less than 0.05. Given the data, it can be inferred that 
there is a significant difference in the psychological and 
physiological effects of the signs and symptoms of PCOS 
between the Diagnosed PCOS Group Pre-treatment and Post-
treatment. 
Tables 7 and 8 determined the reasons for rejecting and seeking 
diagnosis between the Undiagnosed PCOS Group and 
Diagnosed PCOS Group, respectively. Frequency count and 
percentage frequency were used to quantify the responses. 
Additionally, one part of the questionnaire was designed 
exclusively for the Diagnosed PCOS Group Post-Treatment, 
which contained follow-up questions regarding their 
perspective on the reasons for rejecting diagnosis after 
treatment. These follow-up (FU) questions are placed after 
every reason for rejecting diagnosis in Table 7. 
The most common reason for rejecting diagnosis in both 
groups, as seen in Table 7, was Scared of being diagnosed with 
Polycystic Ovarian Syndrome (56.3). For the Undiagnosed 
PCOS Group, their most common reason for rejecting diagnosis 
was also due to fear of getting diagnosed with PCOS (62.0%). 
On the contrary, The treatment is expensive (64.6%) was the 
most common reason that led the Diagnosed PCOS Group to 
hesitate getting diagnosed in the past. 
In Table 8, the most common reasons that would lead the 
respondents to seek diagnosis of PCOS were determined. For 
both groups, the most common reason was to reduce further 
complications (87.8%). Similarly, majority of the Diagnosed 
PCOS Group sought to be diagnosed in the past to reduce 
further complications from the disorder (95.6%). Meanwhile, 
To have a healthier lifestyle (84.9%) was the most common 
reason that would lead the Undiagnosed PCOS Group to seek 
diagnosis.
 
3.1 Demographic Profile of the Women who are Exhibiting 
the Signs and Symptoms of Polycystic Ovarian Syndrome 
(PCOS) 
In the study of Ding, Baio, Hardiman, Petersen, and  Sammon 
(2016), only around 50% of the women who met at least two of 
the three criteria for the diagnosis of PCOS are diagnosed. 
Similarly, from the results gathered, the researchers also 
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noticed the disparity between the Undiagnosed and Diagnosed 
PCOS Group, wherein 60.8% of the respondents were 
undiagnosed but are experiencing at least one symptom of 
oligoovulation and at least one of the observable signs and 
symptoms of PCOS. In the study of Hillman and Dale (2018), 
they mentioned that such under-diagnosis may be due to lack 
of awareness regarding the condition, only women with severe 
phenotype consult their doctors, and general practitioner’s 
avoidance of overmedicalization. In the study conducted, 
included in the participant screening is their level of awareness, 
wherein only those who had an awareness level of 2-5 were 
included. Based on the participant screening, only a few of the 
whole Undiagnosed PCOS Group had an awareness level of 5 
which is knowing how PCOS happens, its signs and symptoms, 
treatment, and further complications that might arise from it. 
Such indicates that even though the respondents were aware of 
PCOS, only a few know all the information regarding the said 
condition. Similar to what Hillman and Dale (2018) discovered, 
this may imply that women consult their doctors only when the 
PCOS has become more severe or they begin to experience 
more signs and symptoms of the condition. 
According to the National Institute of Health (NIH), the adult 
diagnostic criteria for definitive symptoms of PCOS includes  
(1)  hyperandrogenism  and/or hyperandrogenemia, (2) 
Oligoovulation, and (3) Polycystic Ovarian Morphology 
(PCOM). In the study, the researchers made use of the first two 
criteria in screening the participants. From the data gathered, 
the top three most prevalent symptoms include Irregular 
menstrual cycle or having no period at all, Psychological 
disturbances, and Oily skin/acne, consecutively. Both the top 
one and three symptoms recorded coincides with what the study 
of Rebar (2018) discovered to be the most common symptoms 
manifested by women with PCOS; which are irregular 
menstruation cycle and   hyperandrogenism.   From   these   
findings,   it   can be observed that the significant affinity of 
Irregular menstruation or having no period at all with PCOS 
is attributed to the condition’s nature of hormonal imbalances 
such as the abundance of male hormones caused by 
hyperandrogenism. This is further supported by Zeng, Xie, Liu, 
Long, Lian, and Mo (2020), who identified hyperandrogenism 
as the most significant manifestation of PCOS. Furthermore, 
aside from the hormonal imbalance that may also cause oily 
skin that can result in acne, the age of the majority of the 
respondents (18-25) may have  contributed as well. This is 
supported by Reese (2018) who mentioned that although acne 
can affect people of all ages, the most affected group are those 
in between the ages of 12 to 24. In Table 3, 75.4% of the 
population said that they have experienced Psychological 
disturbances associated  with their condition. This clearly 
indicates that mental health may be affected when a person has 
PCOS or is experiencing the signs and symptoms of PCOS. 
Similar findings were also observed from the study conducted 
by Chaudhari, Mazumdar, and Mehta (2018), wherein they 
concluded that anxiety and depression are prevalent in patients 
with PCOS. Additionally, in Figure 3, all of the patients 
experienced more than one of the signs and symptoms of 
PCOS, thus it can be deduced that the coexisting physiological 
problems may have also contributed to the psychological 
disturbances, affecting the confidence and personality of the 
woman with PCOS or exhibiting its signs and symptoms. This 
is further supported by Kubacky (as cited by Parker, 2015), who 
mentioned that the disorder has indeed had a significant impact 
on mental health of a person with PCOS in both situational and 
chemical levels. In addition, aside from the cosmetic issues and 
other symptoms such as having acne, male-pattern baldness, 
and weight gain, the hormonal imbalances brought by the 
condition also cause real neurobiological effects on the brain 
which can be linked to depression. 
Difficulty getting pregnant has been identified as the least 
common symptom of PCOS in the study. Although in other 
studies, difficulty in getting pregnant is generally one of the 
common symptoms of PCOS; the study conducted was not able 
to witness a high frequency in the said symptom. According to 
Bersales (2018) of the Philippine Statistics Authority, the 
median age of mothers giving birth in the Philippines during 
2017 was 26 years old. Given this, the reason for low frequency 
may possibly be attributed to having the majority of the 
respondents being within the age bracket of 18-25 (90.3%). 
Additionally, the majority of the respondents also had a civil 
status of Single (96.5%), which may imply that most of them 
have not yet conceived a child. 
3.2 Prevalence of the Psychological Effects of the Signs 
and Symptoms of Polycystic Ovarian Syndrome (PCOS) 
The fear of cancer is one that is seen throughout the general 
population, as it is feared more than any other disease (Vrinten, 
van Jaarsveld, Waller, Wagner, & Wardle, 2014). As PCOS is 
known to increase the risk of developing cancer (Harris & 
Terry, 2016; Barry et al., 2014), its presence would cause a 
great amount of worry in women once educated on the possible 
complications of the disorder. Murphy, Malrow, Waller and 
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Vrinten (2018) have noted that there is a higher frequency of 
cancer worry in younger age groups and in women, both of 
which describe the majority of the respondents to this study. 
This fear is a common reaction to PCOS, as Copp et al. (2019) 
have associated the reaction of shock and anxiety upon hearing 
of associated long-term risks (inclusive of endometrial cancer) 
of the disease. The difference of the means of the Diagnosed 
PCOS Group before treatment (3.18) and after treatment (2.82) 
indicates a lower occurrence of the psychological effect that 
may be due to diagnosis, yet it became the most prevalent for 
the Diagnosed PCOS Group Post-treatment. The fear of cancer 
is seen as a general health concern and was the most prevalent 
for the Undiagnosed PCOS Group; it can be then understood 
that there was a lack of immediate health issues and they had 
perceived themselves as healthy. Meanwhile in the Diagnosed 
PCOS Group Pre-treatment, there was a concern from weight 
gain; a manifestation of PCOS that is hard to control without 
proper intervention (i.e. no knowledge that it is caused by the 
disorder). Without any noticeable threat to their health, it had 
allowed the Undiagnosed PCOS Group to worry more about 
diseases that could occur at any time regardless of their current 
health status such as cancer, a highly variable disease in its 
causality. While PCOS in its less severe manifestation could 
also fit this criteria, cancer is comparatively more well-known. 
The fact that fear of cancer became once again prevalent in 
those who were diagnosed after their treatment could be 
because of effective intervention, leading to their biggest 
concern being the long-term risks of the disorder instead of the 
immediate complications. 
The Undiagnosed PCOS Group from Table 4.1 also reported 
the psychological effect caused by the signs and symptoms of 
PCOS that they are most concerned with is being afraid of 
getting cancer, which is a complication of PCOS. According to 
Copp et al. (2019), women who have received clinical diagnosis 
of PCOS have had negative feelings such as shock and fear 
when they were diagnosed with PCOS and informed of its 
complications, particularly its associated risk to endometrial 
cancer. Thus, diagnosis and awareness of PCOS can be 
associated with an individual’s fear of the disorder. The 
Undiagnosed PCOS Group does not present the same case as 
the study by Copp et al. (2019) because no diagnosis has been 
conducted to provide them with information about the 
complications of PCOS. However, on the basis of the eligibility 
criteria of the study, the Undiagnosed PCOS Group was 
expected to at least know PCOS and some of its symptoms 
despite not receiving any form of medical consultation as the 
basis of diagnosis. Among the group of participants, it can be 
determined that the level of awareness of some of the women 
of Undiagnosed PCOS Group extended to having an idea of 
PCOS and its association to risk of endometrial cancer, a 
possible explanation as to why the most common psychological 
effect of the sign of PCOS is the fear of getting cancer. Based 
on the initial participant screening, the Undiagnosed PCOS 
Group was indicated to have sufficient awareness on PCOS and 
its symptoms and complications. In addition, there was a 
general fear of getting cancer which has been indicated to be 
the greatest health fear (Vrinten, van Jaarsveld, Waller, von 
Wagner, & Wardle, 2014), providing evidence as to why the 
prevalent psychological concern among the group is the risk of 
cancer development, whether it is due to its association of 
PCOS or due to general fear of cancer. 
As for the Diagnosed PCOS Group Pre-treatment, the concern 
about gaining weight was the most prevalent psychological 
effect felt. Jones et al. (2004) had found that weight gain had 
the highest negative impact in association with PCOS due to the 
difficulty of managing the particular manifestation. Barber, 
Hanson, Weickert and Franks (2019) second the association, as 
their collection and analysis of studies on the relationship 
between obesity and PCOS showed a complex relationship 
influenced by multiple factors, one of which includes mental 
health. In addition, the study had found that women with PCOS 
are prone to developing mental health issues such as anxiety 
and depression, which together with the lower self-worth and 
negative perception of their own body image due to other 
symptoms of PCOS (i.e., manifestations of hormonal 
imbalance such as hirsutism), lead to crippled attempts of 
weight management through lifestyle choices (lowered 
physical activity, ineffective/inconsistent dieting, sleep 
deprivation). The fear of weight gain also may be attributed to 
the fact that the respondents are women. In a study by Lillis, 
Thomas, Levin and Wing (2017), the researchers stated that 
weight self-stigma (referred to as the internalization of bias, 
ridicule and discrimination due to their weight) stems from both 
self-devaluation and fear of enacted stigma (anticipating to 
receive stigma from others). Results from the study show a 
higher occurrence of this phenomenon in women, while also 
having a positive correlation with symptoms of anxiety and 
depression; which then coincide with the previously mentioned 
study. The high concern for weight gain among those diagnosed 
with PCOS may then be attributed to PCOS itself compounding 
inherent social bias towards women regarding their weight. 
Thus as the most prevalent reason for seeking diagnosis for the 
 INTERNATIONAL JOURNAL OF PROGRESSIVE RESEARCH IN SCIENCE AND ENGINEERING, VOL.2, NO.9, SEPTEMBER 2021. 
  
JESSICA Z. LAGUITAO., et.al: AWARENESS ON POLYCYSTIC OVARIAN SYNDROME: A COMPARATIVE STUDY ON THE HEALTH-
RELATED QUALITY OF LIFE BETWEEN DIAGNOSED AND UNDIAGNOSED WOMEN AGED 18-49 206 
 
Diagnosed PCOS Group was To reduce further complications 
(95.6%) the lowered mean score for the concern of weight gain 
before (3.38) and after (2.28) treatment may indicate an 
effective intervention. 
3.3 Prevalence of the Physiological Effects of the Signs 
and Symptoms of Polycystic Ovarian Syndrome (PCOS) 
Irregular menstruation is the physiological sign or symptom of 
PCOS that had the most effect on all groups with a score of 3.39 
which translates to often experienced. This is in line with the 
results of Table 3 where it is the most prevalent among the signs 
or symptoms of PCOS. Irregular menstrual cycle or having no 
period at all is experienced by 82.1% of the respondents. 
Oligoovulation is a condition that is directly related to irregular 
or infrequent menstruation and in the study, one of the 
requirements to be eligible to participate is to have at least one 
symptom of oligoovulation. Moreover, the choices given under 
oligoovulation in the participant screening part of the 
questionnaire included only Painful and/or irregular 
menstruation and Difficulty in pregnancy as the individual 
symptoms. Given that 96.5% of the respondents were single, it 
can be inferred that the respondents had Painful and/or 
irregular menstruation as their symptom for oligoovulation. 
The Rotterdam criteria for PCOS Diagnosis includes 
hyperandrogenism, oligoovulation, and PCOM, where having 
at least two of the three conditions is enough to be diagnosed 
with the disorder (Rosenfield & Ehrmann, 2016, p. 469). With 
that, it is probable that the Diagnosed PCOS Group Pre-
treatment experienced oligoovulation which led to their 
diagnosis. Treatment for the symptoms of PCOS is not 
accomplished in an instant, as addressed in “Polycystic Ovary 
Syndrome Treatment in Philippines” (2016). For example, in 
irregular menstruation, a regimen of oral contraceptives or 
intermittent progesterone tablets must be taken every 3-4 
months or monthly. The time that it takes to achieve a regular 
menstruation cycle may contribute to the burden given by the 
symptom even after diagnosis. 
The existing diagnostic criteria for PCOS are all inclusive of 
irregular menstruation or ovulation cycles (Capozzi, Scambia, 
& Lello, 2020; Rebar, 2018). However, the Undiagnosed PCOS 
Group have no clinical or biochemical tests to utilize as the 
basis for determining that the cause of irregularities to their 
menstrual cycle is due to PCOS; therefore, there is no definitive 
and direct association of irregular menstruation to PCOS 
among the group. In order to determine if irregular 
menstruation is indirectly caused by PCOS, its associated 
factors that can also cause oligomenorrhea or oligoovulation 
must be taken into consideration. According to Park, Shin, 
Jeon, Cho and Kim (2021), irregular menstruation can be 
influenced by factors such as body weight and sleep. In terms 
of body weight, PCOS can be indirectly associated with 
irregular menstruation experienced by undiagnosed women 
because of hyperandrogenism, a biochemical symptom of 
PCOS which manifests through elevated free or total 
testosterone in women. Increased testosterone levels can lead to 
excessive weight gain, which can then influence irregular 
menstruation cycles (Basile & Rodriguez, 2020). Similarly, 
irregular menstruation among the Undiagnosed PCOS Group 
can be indirectly associated to PCOS based on the factor of 
sleeping behavior, as PCOS has been reported to increase the 
risk of obstructive sleep apnea (“Health Risks Associated with 
PCOS - UChicago Medicine,” 2018). In order to explain the 
prevalence of irregular menstruation cycles among 
undiagnosed women as a possible indirect manifestation of 
PCOS, it is important to take note of said factors and how they 
relate to PCOS, when there is not clinical or biochemical basis 
for determining that PCOS is the primary cause of the 
aforementioned physiological concern. 
3.4 Significant Difference in the Psychological and 
Physiological Effects of the Signs and Symptoms of 
Polycystic Ovarian Syndrome (PCOS) 
The Undiagnosed PCOS Group presented an AWM of 2.48 
(sometimes) for the psychological effects and 2.58 (often) for 
the physiological effects, while the Diagnosed PCOS Group 
Pre-treatment presented an AWM of 2.87 (often) and 2.81 
(often), respectively. The latter group showed a higher AWM 
in both psychological and physiological effects. The significant 
difference between the two groups is attributed to the higher 
impact of the psychological and physiological effects of the 
signs and symptoms of PCOS on the Diagnosed PCOS Group 
Pre-treatment respondents compared to the Undiagnosed PCOS 
Group respondents. This may suggest that the former group 
chose to undergo clinical diagnosis because the psychological 
and physiological effects experienced were more prevalent and 
were negatively affecting their lives. The varying clinical 
manifestations among patients tend to be overlooked due to the 
commonality of symptoms of PCOS. This, along with  the 
insufficient knowledge on PCOS contribute to delayed 
diagnosis. Additionally, Hillman and Dale (2018) mentioned 
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that mostly women with a more severe phenotype go through 
medical consultation. Several diagnostic tests and laboratory 
procedures need to be conducted in order to diagnose PCOS 
(Mayo Clinic Staff, 2020). Individuals do not immediately 
present themselves to consultation unless the effects of the 
symptoms have negatively affected their health-related quality 
of life. This may explain as to why the Diagnosed PCOS Group 
is associated with a higher AWM compared to the Undiagnosed 
PCOS Group. 
With an AWM of 2.18 and 1.69, the psychological and 
physiological effects of PCOS post-treatment sometimes and 
rarely affect the group, respectively. These results were lower 
as compared to the respondents’ results before they received 
treatment, which were depicted as often affected. As indicated 
in Tables 4.1 and 4.2, the impact of the psychological and 
physiological symptoms of PCOS were lesser after the 
Diagnosed PCOS Group received treatment. Such is also 
supported by the result of the t-test seen in Table 
There is no definite treatment for PCOS; however, its 
symptoms can be managed through lifestyle improvements 
(Rocha et al., 2019) or through the use of hormonal 
contraceptives  such  as  oral  pills, dermal patches or vaginal 
rings to control menstrual irregularities, hirsutism and acne 
(Williams et al., 2016). Supporting the results acquired from the 
data treatment, it was mentioned in “Polycystic Ovary 
Syndrome: What Is It and How Do You Treat PCOS” (2018) 
that through the introduction of hormones by medications such 
as birth control, the body’s hormone levels return to normal and 
thus help minimize the symptoms of PCOS. Managing PCOS 
helps regulate periods and lessen the pain associated with 
menstruation, decrease acne formation through reduced 
testosterone and inflammation, and stop amenorrhea which 
decreases the risk of developing ovarian cysts. 
3.5 Most Common Factors that Affect the Decision to 
Reject Diagnosis of Polycystic Ovarian Syndrome 
(PCOS) between the Undiagnosed PCOS Group and 
Diagnosed PCOS Group 
For both groups, majority of the respondents said that their 
reason for rejecting diagnosis is because of their fear of getting 
diagnosed with the PCOS condition. However, by separating 
the answers of the two groups, it can be recognized that most of 
the respondents who were afraid of being diagnosed came from 
the Undiagnosed PCOS Group. These findings can imply that 
even though the chosen respondents for the undiagnosed group 
had some knowledge about PCOS, such fear may suggest that 
they still do not fully understand what the condition is and how 
it can affect their health in the long-term. There is also a 
possibility that they are not aware of how the process of 
diagnosis is done and the benefits that can be achieved from 
being diagnosed and receiving treatment for their condition. 
Another reason may also be brought by the lack of accessible 
information that promotes the awareness and understanding of 
the PCOS condition in the public. Taber, Leyva, and Persoskie 
(2015) also mentioned that other reasons why people avoid 
medical care is due to low perceived need to do so and 
traditional barriers such as high cost, lack of health insurance, 
or time constraints. 
There were three reasons which were selected by majority or 
more than 50% of the Undiagnosed PCOS Group as the factors 
for rejecting diagnosis; the following are: Scared of getting 
diagnosed with Polycystic Ovarian Syndrome (62.0%), Afraid 
of the procedure that will be performed in diagnosing 
Polycystic Ovarian Syndrome (55.1%), and It is a hassle to go 
to the hospital (52.2%). The objective of the follow-up 
questions was to identify if there is an advantage to diagnosis 
despite such impediments. The results of the follow-up 
questions answered by the diagnosed group after treatment 
found in Table 7 were correlated to the common reasons for 
rejecting diagnosis of the undiagnosed group. For Scared of 
getting diagnosed with Polycystic Ovarian Syndrome, 92.4% of 
the respondents claimed that getting diagnosed was worth it 
despite the existing fears. Next, in Afraid of the procedure that 
will be performed in diagnosing 
Polycystic Ovarian Syndrome, 81.65% of the respondents said 
that undergoing the treatment procedure was worth it despite 
the risk. Lastly, for It is a hassle to go to the hospital, 88.0% of 
the respondents answered that going to the hospital was worth 
it despite the inconvenience. 
The Diagnosed PCOS Group hesitated to get diagnosed for 
PCOS mostly because the treatment is expensive. This could be 
attributed to the majority of the respondents being at a point in 
their lives where they were financially unable to shoulder the 
expenses of treatment. According to Table 1, 90.3% of all 
respondents are aged 18-25. The Philippine Statistics Authority 
(2017) categorizes the population aged 5-24 years old as the 
“school-age”; this implies that the majority of the respondents 
are either students or newly  hired workers. Additionally, as 
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stated by Taber, Leyva, and Persoskie (2015), high cost of 
medical care is one of the traditional barriers that could deter a 
person from seeking medical attention. Treatment options for 
PCOS vary depending on the symptoms a patient has (NHS 
Choices, 2017). 
3.6 Most Common Factors that Affect the Decision to 
Seek Diagnosis of Polycystic Ovarian Syndrome (PCOS) 
between the Undiagnosed PCOS Group and Diagnosed 
PCOS Group 
Among the Undiagnosed PCOS Group, To have a healthier 
lifestyle was the factor that had the highest frequency (84.9%), 
while for the Diagnosed PCOS Group, it was To reduce further 
complications (95.6%). These two factors ranked not far from 
one another, with their frequencies only differing by small 
values. PCOS is characterized by irregular menstruation and 
symptoms of hyperandrogenism. The presence of these clinical 
symptoms may have prompted those affected to seek diagnosis 
in order to alleviate the manifestations and to achieve health 
management. According to Copp et al. (2019), an increase in 
understanding of PCOS was obtained after diagnosis. This may 
indicate that women diagnosed with PCOS have more 
knowledge on the possible complications brought by the 
hormonal disorder, and thus look towards diagnosis to reduce 
the risk of developing long-term health risks. In addition, the 
symptoms obtained from the hormonal imbalance of PCOS 
may progress to further complications if not maintained. These 
may justify why reducing further complications has a high 
frequency percent, ranging from 83-96%. The clinical 
intervention for PCOS is focused on the management of the 
symptoms and manifestations of PCOS. This applies to the 
Undiagnosed and Diagnosed PCOS Group as they are both 
affected by the symptoms of PCOS. As stated by Rocha et al. 
(2019), lifestyle improvement is one of the standard 
maintenance in controlling hormonal imbalance, thus 
explaining why having a healthier lifestyle was consistently 
obtained at a high frequency percent among the respondents. 
As there is no absolute cure for PCOS, treatment options vary 
and are aimed towards maintenance of symptoms, lifestyle 
improvement, and prevention of further complications. PCOS 
is also considered as the leading cause of female infertility 
(Fabio & Melissa, 2020). This shows that having a healthier 
lifestyle, reducing further complications, planning childbirth, 
and confirming diagnosis are all applicable reasons for 
diagnosis which may vary among women depending on their 
area of concern. 
3.7 The Difference in the Health-Related Quality of Life 
(HRQoL) between the Undiagnosed PCOS Group and 
Diagnosed PCOS Group 
There is a significant difference in the HRQoL between the 
Undiagnosed PCOS Group and Diagnosed PCOS Group based 
on a correlation of the findings of the study. The difference in 
HRQoL is indicated through two specific pairs for comparison: 
(1) Undiagnosed PCOS Group and the Diagnosed PCOS Group 
Pre-treatment, (2) the Diagnosed PCOS Group Pre-treatment 
and the Diagnosed PCOS Group Post-treatment. Based on the 
findings of Table 5, a significant difference was seen on the first 
comparison through the use of an Independent sample t-test, 
which identified that the diagnosed women were often affected 
by both the psychological and physiological effects of 
Polycystic Ovarian Syndrome before their treatment. However, 
while it had been reported that the Diagnosed PCOS Group Pre-
treatment was more affected, the undiagnosed women also had 
an AWM describing that they were still affected by the effects 
of PCOS to some degree. Specifically, their AWM determined 
that they are sometimes affected by the psychological effects 
and often affected by the physiological effects. Moreover, the 
findings of Table 8 presented that 84.9% of the undiagnosed 
group felt that seeking diagnosis was necessary to have a 
healthier lifestyle, while 82.9% wanted to reduce further 
complications. It is important to note that although the 
undiagnosed group are not often affected by both aspects of 
PCOS as compared to the more affected Diagnosed PCOS 
Group Pre-treatment, more than 50% of these undiagnosed 
women admitted to having a need to seek diagnosis. The 
correlation of these findings are indicative that although there 
is a higher negative impact on the diagnosed women, the 
undiagnosed women still present similar signs and symptoms. 
These findings also imply the need for the Undiagnosed PCOS 
Group to seek medical consultation. This recommendation is 
further strengthened by the second comparison, which focuses 
on the effects of PCOS on the diagnosed women before and 
after their treatment. There is a difference in the HRQoL 
between the Diagnosed PCOS Group Pre-treatment and Post-
treatment as observed in the results of Table 6. The Paired 
sample t-test demonstrated a significant difference in the 
psychological and physiological effects of PCOS between the 
two groups. This difference is also supported by the lower 
AWM of the diagnosed respondents after they received 
 INTERNATIONAL JOURNAL OF PROGRESSIVE RESEARCH IN SCIENCE AND ENGINEERING, VOL.2, NO.9, SEPTEMBER 2021. 
  
JESSICA Z. LAGUITAO., et.al: AWARENESS ON POLYCYSTIC OVARIAN SYNDROME: A COMPARATIVE STUDY ON THE HEALTH-
RELATED QUALITY OF LIFE BETWEEN DIAGNOSED AND UNDIAGNOSED WOMEN AGED 18-49 209 
 
treatment. These results suggest that there is an improvement in 
the HRQoL of women due to the effects of the symptoms of 
PCOS getting lower after receiving treatment. The 
improvement in the HRQoL of the Diagnosed PCOS Group 
after receiving treatment signifies that identification of PCOS 
and health maintenance of its symptoms can help reduce the 
health risks associated with PCOS. This is supported by the 
positive outlook of women after diagnosis as observed in the 
results. There are several factors that discourage women from 
getting diagnosed, with the most common ones being scared to 
get diagnosed with PCOS, afraid of the diagnostic procedure of 
PCOS, and that going to the hospital is a hassle. Diagnosed 
women after treatment were given the opportunity to answer 
follow-up questions regarding these factors, and a high 
percentage demonstrated that these impediments towards 
diagnosis are worth going through. Additionally, it is depicted 
in Table 8 that the actions towards health maintenance are 
influenced by the effects of PCOS on their lives. Reducing 
further complications of PCOS and having a healthier lifestyle 
were the most common reasons for seeking diagnosis for the 
Diagnosed PCOS Group, and this may be attributed to their 
knowledge regarding the disorder, which is usually obtained 
after going through a medical consultation. They are more 
informed of the long-term health risks and have a better 
understanding of the importance of a healthy lifestyle. 
IV. CONCLUSIONS 
Based on the data gathered, there was a significant 
difference in the the health-related quality of life (HRQoL) 
between women diagnosed with Polycystic Ovarian Syndrome 
(PCOS) and undiagnosed women who have the signs and 
symptoms of PCOS, aged 18-49 in the National Capital Region 
(NCR). The Diagnosed PCOS Group Pre-treatment chose to 
undergo clinical diagnosis because the psychological and 
physiological effects of PCOS had a higher negative impact on 
their HRQoL as compared to the Undiagnosed PCOS Group. 
Moreover, the effects of the signs and symptoms of PCOS were 
lessened after the diagnosed group received treatment. 
Nevertheless, even if the impact is lesser on the undiagnosed 
group, the effects of the symptoms of PCOS still affected them. 
The impact of these effects on the Undiagnosed PCOS Group’s 
HRQoL may have contributed to their reason to possibly seek 
diagnosis for a healthier lifestyle. The improvement in the 
HRQoL of women after receiving diagnosis suggests that 
awareness among women of reproductive age on the medical 
significance and clinical symptoms of PCOS helps encourage 
women to undergo immediate diagnosis of PCOS in order to 
reduce the associated complications and to have a healthier 
lifestyle. This is supported by the response of the Diagnosed 
PCOS Group Post-treatment where they denoted that clinical 
diagnosis is advantageous despite the common factors that 
inhibit diagnosis. A better understanding on PCOS is achieved 
after clinical diagnosis as women who have been diagnosed 
take measures towards health maintenance and improving their 
health-related quality of life. 
Recommendations: 
PCOS affects women that are within reproductive age 
and the reproductive age range is 15-49 years old. This study 
focused only on women aged 18-49 years old and did not 
include minors due to ethical considerations. The whole 
reproductive age range of women may be included (ages 15-
17), with research ethics in consideration. Including them in the 
study would be beneficial to providing a more comprehensive 
understanding on the effect of PCOS on the HRQoL of 
diagnosed and undiagnosed women. Such can help in 
promoting awareness on PCOS to younger demographics. 
The psychological aspect of PCOS is not frequently 
emphasized on existing literature. Some factors brought about 
by PCOS have been associated with higher rates of anxiety and 
depression. Additional studies on the link of PCOS with its 
psychological aspects and how it affects the quality of life 
(QOL) are recommended for further studies. The current 
studies on the prevalence of physiological signs and symptoms 
may be correlated to the psychological signs and symptoms of 
PCOS; therefore, it is important to conduct future studies on 
how the identified physiological manifestations of PCOS also 
function as factors contributing to the psychological conditions 
of Filipino women with PCOS. Some of the psychological 
disorders associated with PCOS which can be evaluated may 
include depression, anxiety, and eating disorders. 
Numerous researches have studied and proved the relation of 
PCOS with many long-term health risks. This has also been an 
objective of the study which was only mentioned but not 
focused on the questionnaire. It is recommended that questions 
regarding the long-term health problems associated with PCOS 
should be incorporated into the data instrumentation to further 
provide knowledge and awareness on the disorder. In addition, 
the association of PCOS and cardiovascular disease has long 
been debated and thus the results of the future researchers may 
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be used as supplemental information regarding their 
connection. 
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